| scholarly article | Q13442814 |
| P50 | author | John F. Cryan | Q29653562 |
| Klemens Kaupmann | Q68233511 | ||
| Bernhard Bettler | Q87096813 | ||
| P2093 | author name string | Cedric Mombereau | |
| Conrad Gentsch | |||
| Frederique Chaperon | |||
| Kurt Lingenhoehl | |||
| Peter H Kelly | |||
| Will P J M Spooren | |||
| Wolfgang Froestl | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 952-963 | |
| P577 | publication date | 2004-04-27 | |
| P1433 | published in | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
| P1476 | title | Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines | |
| P478 | volume | 310 |
| Q37585413 | ADX71441, a novel, potent and selective positive allosteric modulator of the GABA(B) receptor, shows efficacy in rodent models of overactive bladder |
| Q35641953 | Activation of the GABA(B) Receptor Prevents Nicotine-Induced Locomotor Stimulation in Mice |
| Q42641765 | Activin tunes GABAergic neurotransmission and modulates anxiety-like behavior. |
| Q34389125 | Administration of GABA(B) receptor positive allosteric modulators inhibit the expression of previously established methamphetamine-induced conditioned place preference |
| Q37420482 | Allosteric modulators of GABA(B) receptors: mechanism of action and therapeutic perspective. |
| Q37838926 | Animal Models of Anxiety and Anxiolytic Drug Action |
| Q36258128 | Anxiety-like behaviors at the end of the nocturnal period in sP rats with a "history" of unpredictable, limited access to alcohol |
| Q34415017 | Assessment of GABA-B, metabotropic glutamate, and opioid receptor involvement in an animal model of binge drinking |
| Q40462255 | Behavioral evaluation of mice deficient in GABA(B(1)) receptor isoforms in tests of unconditioned anxiety. |
| Q35039864 | Bidirectional enantioselective effects of the GABAB receptor agonist baclofen in two mouse models of excessive ethanol consumption. |
| Q36323518 | Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission. |
| Q34693009 | CGP7930: a positive allosteric modulator of the GABAB receptor. |
| Q24650641 | Characterization of (R,S)-5,7-di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one as a positive allosteric modulator of GABAB receptors |
| Q42959792 | Chemistry and pharmacology of GABAB receptor ligands |
| Q36358858 | Clinical potential of GABAB receptor modulators. |
| Q36095127 | Comparison of the Effect of the GABAB Receptor Agonist, Baclofen, and the Positive Allosteric Modulator of the GABAB Receptor, GS39783, on Alcohol Self‐Administration in 3 Different Lines of Alcohol‐Preferring Rats |
| Q30539539 | Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice |
| Q48315314 | Decreased GABAA and GABAB receptor functional activity in cannabinoid CB1 receptor knockout mice |
| Q45237034 | Differential sensitivity to the motor and hypothermic effects of the GABA B receptor agonist baclofen in various mouse strains |
| Q36642400 | Discriminative Stimulus Effects of the GABAB Receptor-Positive Modulator rac-BHFF: Comparison with GABAB Receptor Agonists and Drugs of Abuse |
| Q90438743 | Diversity of structure and function of GABAB receptors: a complexity of GABAB-mediated signaling |
| Q37705299 | Effect of fendiline on the maintenance and expression of methamphetamine-induced conditioned place preference in Sprague-Dawley rats |
| Q48026060 | Effects of GABA ligands injected into the nucleus accumbens shell on fear/anxiety-like and feeding behaviours in food-deprived rats |
| Q54364129 | Effects of co-administration of the GABAB receptor agonist baclofen and a positive allosteric modulator of the GABAB receptor, CGP7930, on the development and expression of amphetamine-induced locomotor sensitization in rats |
| Q40567047 | Effects of fendiline on cocaine-seeking behavior in the rat. |
| Q35913130 | Effects of the GABAB Receptor-Positive Modulators CGP7930 and rac-BHFF in Baclofen- and γ-Hydroxybutyrate-Discriminating Pigeons |
| Q34954104 | Evaluation of peripheral versus central effects of GABA(B) receptor activation using a novel, positive allosteric modulator of the GABA(B) receptor ADX71943, a pharmacological tool compound with a fully peripheral activity profile |
| Q45113865 | Floxed allele for conditional inactivation of the GABAB(1) gene |
| Q48175705 | Fluoxetine partly exerts its actions through GABA: a neurochemical evidence |
| Q43261524 | GABA(B) receptor modulators potentiate baclofen-induced depression of dopamine neuron activity in the rat ventral tegmental area |
| Q34528033 | GABA(B) receptor-positive modulation decreases selective molecular and behavioral effects of cocaine |
| Q36820569 | GABA(B) receptors: structure and function |
| Q27026530 | GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence |
| Q36905053 | GABAB receptor-mediated, layer-specific synaptic plasticity reorganizes gamma-frequency neocortical response to stimulation |
| Q34214765 | GABAB receptor-positive modulators: enhancement of GABAB receptor agonist effects in vivo |
| Q37775218 | GABAB receptors and depression. Current status. |
| Q37775215 | GABAB receptors in reward processes |
| Q53428761 | GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia |
| Q89867806 | Ginsenoside Rb1 exerts neuroprotective effects through regulation of Lactobacillus helveticus abundance and GABAA receptor expression |
| Q38110306 | Glutamate-based anxiolytic ligands in clinical trials |
| Q37775205 | Heterodimerization of the GABAB receptor-implications for GPCR signaling and drug discovery |
| Q34512419 | Hyperdopaminergia and altered locomotor activity in GABAB1-deficient mice. |
| Q34052435 | Intra-nucleus accumbens shell injections of R(+)- and S(-)-baclofen bidirectionally alter binge-like ethanol, but not saccharin, intake in C57Bl/6J mice |
| Q37172877 | Involvement of GABAB Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu4 Receptor, LSP4-2022. |
| Q37315470 | Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation |
| Q36191594 | Is the GABA B heterodimer a good drug target? |
| Q36316392 | Ligand-guided homology modelling of the GABAB2 subunit of the GABAB receptor |
| Q37018610 | Mechanism-based medication development for the treatment of nicotine dependence. |
| Q27322584 | Mouse hippocampal GABAB1 but not GABAB2 subunit-containing receptor complex levels are paralleling retrieval in the multiple-T-maze |
| Q42676074 | Mu-opioid receptor knockout mice are more sensitive to chlordiazepoxide-induced anxiolytic behavior |
| Q37704644 | Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference |
| Q37774348 | Novel GABA(B) receptor positive modulators: a patent survey |
| Q51804509 | Operant, oral alcoholic beer self-administration by C57BL/6J mice: effect of BHF177, a positive allosteric modulator of GABAB receptors |
| Q48293962 | Pharmacological actions of oximino-propofol analogues at GABA(B) autoreceptors |
| Q30407741 | Positive allosteric modulation of GABAB receptors ameliorates sensorimotor gating in rodent models. |
| Q36074885 | Positive allosteric modulation of the GABA(B) receptor by GS39783 attenuates the locomotor stimulant actions of ethanol and potentiates the induction of locomotor sensitization |
| Q24647023 | Positive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats |
| Q48823493 | Prenatal corticosterone and adolescent URB597 administration modulate emotionality and CB1 receptor expression in mice |
| Q34613495 | Reducing effect of the positive allosteric modulator of the GABA(B) receptor, GS39,783, on alcohol self-administration in alcohol-preferring rats |
| Q42266074 | Reduction by the positive allosteric modulator of the GABAB receptor, GS39783, of alcohol self-administration in Sardinian alcohol-preferring rats exposed to the “sipper” procedure |
| Q42001372 | Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice |
| Q37024161 | Review. Neurobiology of nicotine dependence |
| Q45922543 | Selective effects of benzodiazepines on the acquisition of conditioned taste aversion compared to attenuation of neophobia in C57BL/6 mice. |
| Q96577249 | Structural basis of the activation of a metabotropic GABA receptor |
| Q47653448 | Structural biology of GABAB receptor |
| Q35188148 | Subchronic Administration and Combination Metabotropic Glutamate and GABAB Receptor Drug Therapy in Fragile X Syndrome |
| Q38768076 | Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: involvement of the GABAB and cannabinoid CB1 receptors |
| Q24647779 | Syntheses and optimization of new GS39783 analogues as positive allosteric modulators of GABA B receptors |
| Q38246629 | Targeting GABAB receptors for anti-abuse drug discovery |
| Q36439166 | Targeting opioid receptor heterodimers: strategies for screening and drug development |
| Q60501930 | Targeting the GABAB Receptor for the Treatment of Depression and Anxiety Disorders |
| Q24596842 | The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice |
| Q27305120 | The GABA(B) receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats |
| Q48154460 | The GABA-B positive modulator GS39783 decreases psychostimulant conditioned-reinforcement and conditioned-reward |
| Q34412607 | The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat. |
| Q28476654 | The GABAβ receptor as a target for antidepressant drug action |
| Q30462832 | The age of anxiety: role of animal models of anxiolytic action in drug discovery |
| Q42621607 | The effects of GABA transporter inhibition on synaptophysin and synaptotagmin expression in diazepam tolerance |
| Q28570219 | The oligomeric state sets GABA(B) receptor signalling efficacy |
| Q46915132 | The positive allosteric modulator GS39783 enhances GABA(B) receptor-mediated inhibition of cyclic AMP formation in rat striatum in vivo |
| Q57513959 | The role of GABAB receptors in depression and antidepressant-related behavioural responses |
| Q30481164 | The rostral anterior cingulate cortex modulates the efficiency of amygdala-dependent fear learning |
Search more.